Nonthrombotic pulmonary embolism (NTPE) is a complete or partial occlusion of the pulmonary vasculature by various organic and inorganic materials. These materials include organic particulate matter (PM) such as adipocytes, tumor cells, bacteria, fungi, or gas and inorganic PM.
A small proportion of pulmonary embolisms do not result from thrombus formation and are referred to as nonthrombotic pulmonary embolism (NTPE). 1, 2 Various reports have examined the characteristics of NTPE resulting from "organic" particulate material (PM) ( Table 1) . 1, 3 The purpose of the present article is to provide a review of the literature examining NTPE from inorganic PM and foreign bodies. Although the incidence of NTPE from PM and foreign bodies is relatively low, they still confer a significant risk to patients. 3 Table 2 illustrates the classification of NTPE based on its clinical presentation. We further classified these entities into macroscopic and microscopic, depending on the size of the embolized material and the ability to directly visualize it on imaging (macroscopic) as opposed to studying the indirect effects of the embolized material on the lungs (microscopic).
Accidental Embolization

Macroscopic Emboli
Catheter Tips and Guidewires: Venous access via central venous catheters (CVCs) or an implanted port is a common practice in ICUs. CVCs are associated with complications such as central line-associated bloodstream infections, phlebitis, and catheter fracture with or without downstream embolization ( Fig 1A) . [4] [5] [6] [7] [8] [9] Catheter-tip embolization has an incidence of 0.2% to 4.2% in adults and 1.4% to 3.6% in children. 5, 9, 10 This phenomenon, first described in 1954, has a mortality rate of 1.8%. 9, 11 Tip fracture and embolization leading to an NTPE can occur with any type of catheter placed in the central or peripheral vasculature. A phenomenon called "pinch-off syndrome" can occur when a catheter placed in the subclavian vein gets wedged between the rib and the clavicle, leading to its recurrent compression and subsequent transection and embolization. 9, 12, 13 NTPE can also develop during catheter insertion while removing the guidewire, removal of percutaneous venous catheters, or during catheter exchange. 9, 14 Following the fracture, catheter fragments can become lodged in the superior vena cava, right atrium, right ventricle, pulmonary artery, or the hepatic or brachiocephalic veins (Figs 1B, 1C). 5, 9, [14] [15] [16] [17] Patients may remain asymptomatic or present with catheter dysfunction (especially those with totally implantable venous devices), palpitations, dyspnea, cough, or chest pain. In approximately 25% of cases, embolized catheter fragments are incidentally found on routine chest radiographs (CXRs) or CT scans. 9 Rarely, IVC filter limbs and catheter guidewires may fracture and embolize into the right ventricle or pulmonary circulation. 18 Percutaneous retrieval of the embolized catheters via the femoral route is the gold standard for management (Figs 2A, 2B) . 19 In some instances, percutaneous retrieval of the embolized catheter may not be possible due to ischemic complications, the inability of the catheter-lumen to be wired, insufficient provider expertise, or distal positioning of the catheter. Surgical retrieval via thoracotomy may be required in these circumstances. Milbrandt et al 20 suggested ligating the catheter and leaving the fragment in place as the least invasive modality in selected cases. The literature recommends inserting the catheter into a more distal location or cannulating the internal jugular vein to minimize the risk of pinch-off syndrome.
9,19
Calcified Fibrin Sheath: A calcified fibrin sheath is a complication of long-term use of CVCs. It involves the formation of a fibrin sheath around the catheter, which 21 This situation is often encountered while removing tunneled dialysis catheters, with a reported incidence of 47% (Fig 3C) . 26 Oguzkurt et al 27 reported an even higher incidence of 72% in both shortand long-term catheters by "pull-back" venography. Retained fibrin sheaths are more prevalent in women; up to 47% are calcified and associated with collateral formation due to venous occlusion. chestjournal.org
The prevalence of retained fibrin sheaths detected on CT scans is approximately 13.6% (Figs 3D, 3E). 28 They can also be diagnosed on a routine CXR. Mohamad et al 22 showed that high-resolution T2-weighted MRI combined with high-resolution magnetic resonance cholangiopancreatography is a noninvasive diagnostic method for localization and examination of each lumen of the catheter. Management involves thrombolysis or fibrin sheath stripping or disruption through balloon angioplasty.
Radiation seeds: The implantation of Iodine-125 seeds for the treatment of prostate cancer was first described by Whitmore et al 29 in 1956 (Fig 4A) . These seeds carry a risk of embolization to the pulmonary artery (Figs 4B, 4C). 30 Seed implantation using a transperineal approach is associated with a higher risk of embolization than an open suprapubic approach, presumably because the former requires a much higher number of seeds. 30 Even the ultrasound-guided transrectal route for seed implantation is associated with embolization, with the seeds gaining access to the circulation through the periprostatic venous plexus.
Palladium-103 seeds are also favored as a radiation source. 31 Seeds implanted in close proximity to the urethra or periprostatic tissues have a migration rate of 5.9-55%. The rate of NTPE resulting from distal embolization into the pulmonary vasculature ranges from 0% to 0.7% for vicryl-laden seeds and 0.19% to 0.98% for free radioactive seeds. [32] [33] [34] [35] [36] [37] The exact mechanism of seed loss and pulmonary embolisms remains unknown, 34 although Tapen et al 37 consists of injection of polymethylmethacrylate (PMMA) into a collapsed vertebra. PVP is recommended for pain relief and mechanical strengthening of the vertebral body in cases of malignant osteolytic tumors and osteoporosis ( Fig 5A) . [42] [43] [44] The complications of the procedure include extravasation of the PMMA into the intervertebral space, needle tracks, prevertebral soft tissues, spinal canal, intervertebral discs, prevertebral or epidural veins, metameric artery, inferior vena cava, aorta, or the lungs (Fig 5B) . 43 The extravasation can lead to nerve compression and soft tissue damage. PMMA extravasation can occur in 30% to 72.5% of cases.
43 Figure 2 -A, IV contrast-enhanced CT chest image with coronal maximum intensity projection reconstruction (bone window) demonstrates a linear radiopaque foreign body (guidewire) in the distal right main pulmonary artery extending into the right interlobar and proximal right lower lobe artery. B, Selective catheter pulmonary angiogram. Note cannulation of the right pulmonary artery and fluoroscopic guided retrieval of the embolized guidewire using a snare.
Venous extravasation occurring in approximately 24% of cases can extend into the inferior vena cava asymptomatically, yet occasionally may lead to lifethreatening PE. 45, 46 A case of fat embolism following a vertebroplasty has also been reported, possibly due to displacement of bone marrow and fat with the injection. 47 A systematic review by Taylor et al 48 concluded that kyphoplasty has fewer complications than vertebroplasty.
Although patients with NTPE from PMMA extravasation are largely asymptomatic, they may present with dyspnea, tachypnea, cyanosis, hemoptysis, dizziness, chest discomfort, tachycardia, hypotension, substernal chest pain, cardiac tamponade, cardiopulmonary arrest, and chemical odor of PMMA. 43, 45, [49] [50] [51] It can also progress to include heart failure, pulmonary hypertension, arrhythmias, cardiac rupture, and respiratory distress and, rarely, fatality. 45, 46 Symptoms have been reported to occur immediately to as late as 5 years' postvertebroplasty. [52] [53] [54] NTPE resulting from extravasation of PMMA presents as rounded, linear, or branching high-density opacities on CXR and unenhanced CT scanning. 46 They are seen demonstrate embolized fragmented calcified fibrin sheath with nonmetallic, calcific attenuation material in subsegmental arteries in the right lower lobe and middle lobe. Note that these subtle findings could be missed on lung window images. Even when detected, these may be mistaken as calcified granulomata.
chestjournal.org as hyperdense cement deposits on unenhanced chest CT scans. 55 Use of "bone windows" (window width ¼ 1,500, window level ¼ 300) on contrast-enhanced CT scan can increase the diagnostic yield. 56 Ventilation-perfusion scanning can be useful in demonstrating and quantifying the defect. 57 The embolization could be an incidental finding on transthoracic echocardiography among asymptomatic patients. 45, 49, 53 There is a lack of standardization in the management of PMMA embolization. Conservative management is favored in patients without hemodynamic compromise. 50 Short-term anticoagulation to reduce the risk of thrombus formation on the surface of the embolized cement, for 3 to 6 months have been recommended. 50 This approach, however, remains controversial as the ability of platelet aggregation or plasma coagulation to occur on the surface of PMMA cement is questionable. 58 In patients with clinically significant NTPEs, percutaneous retrieval and surgical embolectomy have been successful. 50, 59, 60 Laredo and Hamze 43 suggest that extravasation of PMMA cement can be minimized by injecting the cement of an appropriate viscosity, performing the procedure under high-resolution bi-plane fluoroscopy, and mixing the PMMA with barium and tungsten for opacification to aid in early detection of venous leakage. 49, 57 It has also been reported that limiting the number of vertebral segments treated by PVP at one time, decreasing the volume of PMMA, and proper expertise may reduce the complication. 47 
Microscopic Emboli
Ethiodized Oil: Management of thoracic duct injury often involves its embolization. 61, 62 Thoracic duct embolization, first described by Cope, 63 is achieved with the use of ethiodized oil (Lipiodol; Guerbet LLC) for opacification of the lymphatic system to visualize the leakage site ( Figs 6A, 6B ). It also helps to direct a guidewire within the lymphatic system under fluoroscopy. [63] [64] [65] The dose of ethiodized oil used in lymphography is 6 to 7 mL injected at the rate of 4 to 10 mL/h into the lymphatics of each extremity. 64 Once visualized, the leakage site is embolized by using microcoils or liquid sealants (Fig 6C) . 62, 66 Potential complications of the procedure include infection, pain, intra-alveolar hemorrhage, allergic reactions to ethiodized oil, or extravasation leading to ethiodized oil embolization to the pulmonary or cerebral vasculature. 62, 67, 68 Pulmonary infarction may occur as a result of mechanical obstruction of the capillaries by the oil droplets. The particles can also cause localized chemical injury and an inflammatory response. 69 The volume of ethiodized oil has been shown to be a major risk factor in the development of NTPE. 63, 70, 71 NTPE usually produces no symptoms unless > 20 mL of ethiodized oil is used or if the patient has poor cardiopulmonary reserve or patent lympho-venous communications. 64 Ethiodized oil embolization may present with hypoxia immediately or several days following the procedure or can be incidentally noted on follow-up imaging.
Pulmonary infiltrates are the most common finding on standard CXR following ethiodized oil embolization. A noncontrast CT scan may reveal diffusely increased attenuation with interstitial thickening and accumulation of iodized oil-like high-density materials within the lungs. 64, 72, 73 Cytologic examination of BAL fluid with Oil Red O staining is useful in the diagnosis when imaging modalities are equivocal. 74 An autopsy in a patient who died from the complications of ethiodized oil embolism revealed alveolar hemorrhage with fat droplet deposition and fibrin thrombi in the pulmonary vasculature.
72
There remains no definitive therapy for ethiodized oil embolism. Management of pulmonary complications following transarterial chemoembolization involves supportive care to mechanical ventilation if required. 75, 76 Low-molecular-weight heparin has been shown to be beneficial in counteracting and preventing further arterial occlusion. 70 Use of heparin, furosemide, nitroglycerin, methylprednisolone, or mechanical ventilation has not been shown to improve the outcomes from this condition.
77,78
Silicone Embolism: Silicone (polydimethylsiloxane) implants are used for breast augmentation and cosmetic procedures. Silicone is ideal for these procedures because of its thermal stability, resistance to changes in physical properties with aging, low surface tension, and minimal tissue reaction. 79 Numerous pulmonary complications have been reported, primarily with subcutaneous cosmetic silicone injections, including ARDS, alveolar hemorrhage, pneumonitis, pulmonary embolism, and death. 80 This entity has also been described in transgender male-to-female patients and in men and women aged 22 to 53 years who receive silicone injections for cosmetic reasons or for competitive bodybuilding. 81 It is postulated that silicone embolism occurs when the site of injection is in close proximity to a venous plexus. The etiology of inflammation has been chestjournal.org hypothesized to involve increased vascular permeability, activation of endothelial cells, accumulation of activated neutrophils and increased immunoregulatory responses as a result of alveolar macrophage ingestion of silicone.
79
"Silicone embolism syndrome" is a relatively acute process, typically manifesting as dyspnea, fever, cough, hemoptysis, chest pain, hypoxia, and an alteration in mental status. 79 The clinical picture has been likened to that of fat embolism syndrome. 82 Patients typically present within a few minutes of silicone injection.
80,83
The diagnosis requires a high degree of suspicion. CXRs may reveal diffuse patchy alveolar infiltrates in the acute phase and increased interstitial markings and hilar adenopathy with chronicity. On a noncontrast CT scan, silicone embolism typically presents as peripheral ground-glass opacities and may be associated with interlobular septal thickening similar to that in fat embolism and eosinophilic lung diseases (Figs 7A, 7B). 81 BAL is notable for a neutrophil-predominant return and alveolar hemorrhage. 84 , 85 Schmid et al, 79 in a series of 34 patients, reported alveolar hemorrhage in 21 (64%). On transbronchial lung biopsy specimens, translucent noncrystalline, non-birefringent, nonstaining globules or lipoid vacuoles can be seen. 85, 86 Dark-field microscopy, Oil Red O stain on formalin-fixed, paraffin-embedded tissue sections, electron microscopy with energydispersive X-ray analysis, and infrared spectroscopy can all be used to confirm silicone particles. 87, 88 Lipoid vacuoles have also been shown on the biopsy specimen. 89 A presentation of severe alveolar hemorrhage and cutaneous lesions in a relatively young patient should raise suspicion for silicone embolism. 90 Management of silicone embolism is largely supportive. The spectrum of respiratory failure can range from mild to severe, needing endotracheal intubation, and ventilatory support. Zamora et al 91 reported resolution of symptoms with IV steroids within 1 month of presentation. 91 The use of venovenous extracorporeal membrane oxygenation and plasmapheresis has also been successful in cases of refractory hypoxemia. 86, 92 Silicone used in breast augmentation can also embolize to the lungs, albeit rarely, leading to a form of NTPE known as chronic pulmonary silicone embolism. 80, 83 In contrast to the silicone embolism syndrome, symptoms in the few reported cases of this entity have appeared several years after breast augmentation. Gopinath et al 83 reported a case of chronic silicone embolism 8 years after breast augmentation. 82, 86, 93 Arora et al 86 have
reported a similar case in a woman with saline implants 18 years following breast augmentation. Pathologic examination in such cases shows silicone globules within or adjacent to the pulmonary microvasculature, occasionally surrounded by foreign body-type granulomas (Fig 7C) . 83 Talc Granulomatosis: IV injection of the drugs intended for oral use can result in the formation of foreign body-type granulomas in the perivascular interstitium of the lungs due to entrapment of "filler" materials within these pills. 94, 95 These excipients are particulate substances that impart bulk and other physical properties to oral pills. In the past, the most common filler was talc, hence the designation "talc granulomatosis," but currently microcrystalline cellulose and crospovidone are more commonly encountered. The medications commonly abused in this manner include methadone, methylphenidate, pentazocine, hydromorphone, tripelennamine, cyclobenzaprine, amphetamines, and dextroamphetamine. Once trapped within the pulmonary capillaries, filler particles extrude into the interstitium, resulting in the formation of granulomas. The process may progress to pulmonary chestjournal.org hypertension or fibrosis, especially in the perihilar region and upper lobes. 96, 97 With repeated exposure, patients may develop panacinar emphysema with a predilection for the lower lobes, presumably caused by obstruction and thrombosis of smaller blood vessels and subsequent lung ischemia. 98 NTPE due to talc granulomatosis is rare but may be progressive and fatal. Patients commonly present with fever, dyspnea, hypoxia, or hemoptysis. Because this type of activity is illicit, the history of drug abuse in this manner may not be forthcoming. In addition, individuals with this diagnosis do not always fit the clinical profile of a "typical" IV drug user. The clinical syndrome can include interstitial pneumonia, pulmonary hypertension, or cor pulmonale depending on the severity and duration of abuse. 99, 100 In most cases, the diagnosis is confirmed only at autopsy. However, diagnostic features can also be recognized in transbronchial lung biopsy specimens. 95, 98 Patients who are suspected to have talc granulomatosis should undergo a thorough history and medication reconciliation focusing on opioids/stimulants. Clinical clues to the diagnosis include a history of chronic pain requiring opioids, frequent change of medical providers, easy availability of IV access due to other reasons, the presence of needle tracks, or the development of infective endocarditis/bacteremia. CXRs may show scattered or widespread micronodules. 101 Chest CT imaging may reveal multiple bilateral tiny micronodules simulating miliary TB, ground-glass opacities, diffuse tree-in-bud opacities, or lower lobe predominant panacinar emphysema (Fig 8) . 102 The main pathologic finding is the presence of particulate material within the capillaries and perivascular interstitium, surrounded by multinucleated giant cells (Figs 9A, 9B ). 94 Examination under polarized light can be helpful because microcrystalline cellulose and talc are strongly birefringent. 94, 98, 103 The diagnosis can also be supported by the presence of irregularly shaped crystals on fundoscopic examination. 102 Management is largely supportive and nonstandardized.
Yttrium-90 Microsphere Embolization: Yttrium-90 (Y-90) radioembolization is a catheter-directed therapy that involves the introduction of Y-90 microspheres into the vascular supply of liver metastases, originating from neuroendocrine tumors (Fig 10A) . Selective internal radiation therapy (SIRT) allows for whole liver, lobar, and segmental treatment approaches. 104 SIRT provides a choice of radioembolization using 20-to 30-mm glassbased particles (TheraSphere; BTG International, Ltd) or a 20-to 60-mm resin-based agent (SIR-Spheres; Sirtex Medical Inc) ( Figs 10B, 10C ). 105 Although SIRT allows for localized radioembolization of liver tumors, the microspheres can also spread to other organs such as the lungs, causing significant adverse effects. It is postulated that tumor-induced arteriovenous shunting causes the microspheres to bypass the capillary bed, thus allowing for the embolization. 106 Studies have postulated the likelihood of NTPE to shunt fraction of > 13%. 107 Extravasation of Y-90 microspheres into extrahepatic tissues has been reported to cause pancreatitis, hemorrhagic gastritis, cholecystitis, and radiation pneumonitis or a postradioembolization syndrome of nausea/vomiting, abdominal pain, and cachexia. 104, 108 Patients with radiation pneumonitis as a result of Y-90 embolization to the lungs present with a progressive restrictive ventilatory defect. Imaging of the lungs may reveal pleural effusions, atelectasis, and ground-glass attenuation, whereas radiation pneumonitis may be seen as a bat-wing appearance on CT imaging ( Figs 10D,  10E) . 106, 107 The diagnosis is confirmed by the presence of Y-90 microspheres within the lung on histopathologic examination. 107 Management of radiation pneumonitis involves corticosteroids. However, this recommendation remains inconclusive. 108 Some of these complications can be prevented by proper pretreatment mapping using a 99Tc-macroaggregated albumin scan and the use of standard dosimetry models.
109 Figure 8 -Axial CT chest image through the carinal bifurcation (lung window) demonstrates diffuse tiny branching centrilobular opacities ("tree in bud" pattern) in both lungs in a patient who presented to the ED with dyspnea and a history of IV drug abuse.
Therapeutic Embolization
Pulmonary arteriovenous malformations (PAVMs) result from abnormal communications between the pulmonary arteries and veins. They are most often congenital in origin. These malformations may lead to complications that include hypoxia, right-to-left shunts, hemoptysis, paradoxical embolization, brain abscess, platypnea, and orthodeoxia. 110, 111 PAVMs are frequently associated with hereditary hemorrhagic telangiectasia (HHT) (Fig 11A) . Up to 90% of patients with PAVMs have a diagnosis of HHT, whereas only 50% of patients with HHT are likely to have PAVMs. 112 In the diffuse clinical form, mortality is close to 70%. PAVMs are treated with catheter-directed therapeutic embolization of the pulmonary artery immediately preceding the aneurysmal sac. This approach is preferred over surgical intervention because it is less invasive and allows for repeated treatments.
110
Therapeutic embolization is performed by using coils and various vascular occlusion devices (eg, fibered steel and platinum coils, Nester coil, fibered micro-coils, hydrophilic coils, self-expandable nitinol plugs) ( Figs 11B, 11C) . 113, 114 PAVM embolization is associated with complications such as pulmonary infarction, postprocedural pleurisy, gas embolism, infection, hemoptysis, cerebral infarction, reperfusion injury, and device migration. 110, 115, 116 The latter is reported in approximately 1.2% of patients. 117, 118 Pulmonary infarction has been noted on imaging in 3.2% of patients and is believed to be likely a result of occlusion of the pulmonary artery branches proximal to the PAVM. Air embolism during the procedure was suspected in 4.8% of patients. 117, 119 Clinicians caring for patients who have undergone therapeutic embolization should be cognizant of possible reperfusion injury or an acute NTPE. The "feeding vessel sign" on contrast-enhanced CT scans is useful for identifying PAVMs. 120 Contrast-enhanced CT scanning allows for an accurate examination of the architecture of the PAVM, which consists of a feeding artery, the aneurysmal bulb, and a draining vein. 121 They also allow for the visualization of potential complications such as thrombosis of feeding vessels. suggested that patients treated for PAVMs are started on anticoagulation therapy as soon as the retrograde filling of the embolized PAVM is noted. Pre-heparinization and phlebotomy for patients with polycythemia have also been used as a method of preventing NTPE post-embolotherapy. 119 Therapeutic stents have shown benefit in the management of non-balloon-dilatable pulmonary artery stenosis, especially in the pediatric population.
Complications reported from this procedure include stent migration and intraluminal stent obstruction leading to disruption of distal blood flow. 122 These stents can also cause occlusion of side-branch pulmonary arteries. These procedures mandate long-term follow-up for early diagnosis of complications.
Ambulatory pulmonary artery pressure monitoring devices (CardioMEMS HF System; St. Jude Medical, Inc) have been approved for the management of chronic heart failure ( Figs 12A-C) . The sensor occupies approximately 10% of the lumen of the target pulmonary artery and epithelializes within 3 months. Recent data suggest that in just < 3 years since its introduction, there have been 46 cases of sensor failure, malfunction, or migration of a total of 5,500 implantations. 123 Diagnostic Considerations
An accurate diagnosis of NTPE requires knowledge of the diverse imaging findings that fall under this category.
The pattern on CT imaging depends on the clinical scenario and the type of embolization. Scattered tiny radiopaque/metallic densities, centrilobular groundglass opacities, and micronodules/miliary nodules, as well as fibrotic/consolidative opacities, may all indicate NTPE. Noncontrast chest CT imaging is often better in depicting NTPE than contrast-enhanced scans, as radiopaque iodine within the vessel lumen may mask the presence of dense PM. It is important to carefully evaluate wide "lung window" settings for visualization of acquired CT data, especially when particulate emboli are not initially suspected. Most abnormalities can be detected on lung windows, including calcific and metallic foreign matter. It is emphasized that if there is a question on routine lung window images, "bone window" settings may be of value to arrive at a more definitive interpretation. This approach is more chestjournal.org important for contrast-enhanced CT scans and aids in distinguishing metallic particulate foreign bodies from intravascular contrast material. Most modern helical scanners have the capacity to acquire raw data in contiguous thin sections throughout the thorax, which can be formatted to create optimal multiplanar and maximum intensity projection images in axial, coronal, or sagittal planes. These post-processing tools are immensely valuable in the accurate depiction and localization of small intravascular particles, particularly when a foreign matter NTPE is suspected based on initial CXR. Correlation with previous conventional radiographs and fluoroscopic images is paramount in all cases. Previous radiographs may reveal the presence of venous access devices or catheters and help to show temporal evolution of intravascular embolization.
Conclusions
This article provides a review of the current literature regarding NTPE from inorganic PM and foreign bodies. The entities that fall within this designation are all rare.
Patients can present with a wide spectrum of signs and symptoms depending on the nature of the embolized material. Some may remain asymptomatic, while others can develop significant respiratory compromise. A high index of suspicion coupled with a comprehensive history and physical examination lend clues to the likelihood of each diagnosis. Close monitoring and appropriate lung imaging can facilitate early diagnosis. The authors reemphasize the need to familiarize physicians with the different viewing techniques and windows with respect to CT imaging.
